INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• The Workhorse Of Today’s Clinical Trials

  Unlock the power of decentralized clinical trials with an electronic data capture platform (EDC). Discover how stakeholders benefit and what to consider when choosing the right EDC system.

• Metastatic Breast Cancer Rates Show Disparities Between Black And White Patients

  Given that age and screening have observable but not fully explicable effects on risk, a new analysis investigates the racial disparities in breast cancer outcomes.

• Supporting Early Phase Oncology Research With The Right Data Management System

  Better understand how the evolving landscape drives innovation, why your data capture strategy needs the right technology foundation, and what to look for in a CDMS/EDC system for early-phase oncology.

• What To Look For In A Medical Affairs Customer Relationship Management Platform

  Medical affairs teams are constantly looking to connect with new influencers and key opinion leaders. Consider prioritizing these features when exploring tools to manage KOL outreach.

• Still Using Paper Diaries To Capture PRO Data? Read This.

  1/8/2024

  Access real-world examples of how electronic patient-reported outcome measures (PROMs) optimize data quality and reliability and improve the statistical power of trial data.

• The Diversity Imperative: EDC And Inclusive Clinical Trials

  3/4/2024

  In this EDC Showcase, experts delve into the crucial role of EDC in fostering diversity within clinical trials. Discover adaptable solutions for a more inclusive and efficient clinical workflow.

• How Technology Can Empower CAR T-Cell Therapy Clinical Trials

  5/24/2023

  Explore how innovative technologies are pushing advancements in CAR T-cell therapy, enhancing patient outcomes, and streamlining trial processes.

• NeuraLace Doubles Clinical Trial Enrollment & Improves Participant Compliance With EDC & ePRO

  3/20/2023

  Find out how one company dedicated to producing innovative non-invasive chronic pain therapies was able to engage its patients in new ways.

• Why Sanofi Became A Patient-Centered R&D Organization

  12/7/2022

  Sanofi has adopted a Patient Informed Research And Development model within the organization. The goal of the model is to work with patients, patient groups, and patient communities to understand the concerns of patients and ensure those voices are heard throughout the company. The company defines this approach as engaging with patients and caregivers, hearing their concerns, and translating those insights into actions that will help develop meaningful healthcare solutions. Today, Sanofi’s development programs are 100% informed by individuals from the patient communities and 100% of Phase 2 and Phase 3 trials have a remote capability built into them.

  In October 2022, Clinical Leader Chief Editor, Ed Miseta interviewed Victoria DiBiaso, global head, patient informed development & health value translation, and Terttu Haring, head, clinical innovation office at Sanofi. They discussed the new R&D model, the company’s attempts to make its trials more patient-centric, and how digital technologies and devices are helping to create a better trial experience for patients.

  In this segment, DiBiaso discusses the thinking behind the creation of a patient-centered R&D organization.